Cyberonics Corporate Headquarters Fully Operational Following Hur... ( HOUSTON Sept. 22 /- Cyberonics In...)

Cyberonics Corporate Headquarters Fully Operational Following Hurricane Ike

Date:9/22/2008

HOUSTON, Sept. 22 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that its corporate headquarters in Houston, TX has reopened following Hurricane Ike.

The facility incurred no damage from the hurricane, but had been without power for several days, resulting in the Company operating from its disaster recovery facility during that time. All business activities have since returned to normal, including all shipments and production of Cyberonics' Vagus Nerve Stimulation (VNS) Therapy(TM) System.

The Company continues to anticipate that there will be no material impact on its business as a result of the circumstances brought about by Hurricane Ike.

About Cyberonics, Inc. and VNS Therapy(TM)

Cyberonics, Inc. (Nasdaq: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at http://www.cyberonics.com and http://www.vnstherapy.com.

Safe harbor statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the u
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Cyberonics Licenses Obesity-Related Patents
2. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
3. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
4. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Financial Results
5. Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference
6. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results
7. Cyberonics to Present at Canaccord Adams 28th Annual Global Growth Conference
8. Cyberonics to Present at UBS Global Life Sciences Conference
9. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
10. Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association
11. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments

Post Your Comments:

(Date:12/1/2009)...ewswire-USNewswire/ -- The following is being rele...ent: ,, Chairman Kerry, Ranking Member Lugar, a... be nominated by President Obama to serve as Admin...onal Development, and I appreciate his confidence ...e Clinton has expressed the conviction that, along...

(Date:12/1/2009)...hority Encourages Older Persons and Healthcare Wor... Based Upon Authority Data ,, HARRISBURG, Pa.... of all vaccine preventable deaths occur in those ..., according to highlighted studies in the Pennsylv...ient Safety Advisory . ,, According to the Cent...

(Date:12/1/2009)...rforming surgical operations without leaving scars...ty. This is demonstrated by the recent surgical ad...nal Endoscopy Surgery), an innovative surgical app... natural orifices. The results are all advantageou... stay and faster recovery. Currently, this type of...

(Date:12/1/2009)...ness declines with age are more likely to engage i...heir misguided negative view of the aging process ... encourage them to make the most of the present in...ngs 1 by Dr. John Garry and Dr. Maria Lohan from ...published online in Springer,s Journal of Happine...

(Date:12/1/2009)...iversit de Montral researcher, funded by the Inter...d Violence Against Women, has launched a new study... started our research seeking men in their twentie...find any," says Simon Louis Lajeunesse, a postdoct... Work. , "The objective of my work is to observ...

[0] Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 [1] Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory [0] Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus [0] Binge drinking youths find getting old a drag [0] Are the effects of pornography negligible?

...N, Mass., Aug. 5 Indevus,Pharmaceuticals, Inc. (N...sults of operations for the third quarter ended Ju...ll and webcast today beginning at 9:00 am,eastern ...quarter ended June 30,2008. This compares to reven...

... Allsup explains the pros, cons ...owing a long-term disabling event, especially duri...ce benefits , Belleville,...use of a disability, according to http://allsup.c...

... Cenegenics® Medical Institu...nnounced the opening of Cenegenics Indiana. The c...hing over 2008-2009. The new Cenegenics Indiana wi...ptured global media attention, such as 60 Minutes,...

... QHR client hospital Gritman Med...st, Pullman Regional Hospital, were recently ranke...re and Medicaid Services (CMS) in "overall pa...n physician recruitment and share medical equipmen...

... The rapid growth in popularity ...ny skeptics wrong. A recent poll shows that the b...umers, privacy concerns. From dating, through gen... Carlsbad, Calif. (PRWEB) August 5, 2...

...BEACH, Calif., Aug. 5 Today the United States,Pat...ronmentally "Green",low cost process that eliminat...g oxidants. The patent includes methods for abatin... processes,there is a significant increase in effi...

Indevus Pharmaceuticals Announces Third Quarter Fiscal 2008 Financial Results Ten Questions to Ask When Considering COBRA Following a Disability Global Leader In Age Management Announces New Indiana Medical Center Collaborative Efforts Prove Effective for QHR Client Hospital Gritman Medical Center and Neighboring Pullman Regional Hospital DNA Testing and Genetic Profiles Help Avoid Broken Hearts Polls Reveal USPTO Issues Patent Embodying Methodologies for Abating a Broad Range of Allergens, Pathogens, Viruses, Bacteria, Odors and Volatile Organic Compounds.

(Date:12/1/2009)..., , MINNETONKA, Minn., Dec. 1 /PRNewswire/...ology solutions company specializing in clinical s...IGHTEN ®, its industry-leading EDC/eClinical ...nical Data Interchange Standards Consortium (CDISC...M) standard. This certification underscores MedNe...

(Date:12/1/2009)..., , CAMBRIDGE, Mass. and TOKYO, Dec. 1 /PR...al Co., Ltd. announced today the further extension...hrough 2011. This latest extension increases the ...otal committed funding to approximately $90 millio... January 2005 with the goal of discovering and dev...

(Date:12/1/2009)..., , CLEARWATER, Fla., Dec. 1 /PRNewswire/ ...provider of medical supplies, today announced that...ankruptcy Court for District of Delaware (the "Cou... the marketing and proposed sale of substantially ...d November 24, 2009, the Court approved bidding pr...

Breaking Medicine Technology:MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification 2 Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2 Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3 CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2 Evolution of a contraceptive for sea lamprey 8994 1 Evolution of a contraceptive for sea lamprey 8994 2 AAHSA Statement on House Ways and Means Committee Hearing 49988 1 AAHSA Statement on House Ways and Means Committee Hearing 49988 2 Allscripts to Announce Fiscal Fourth Quarter and Year End Results on July 20 2009 49984 1 Allscripts to Announce Fiscal Fourth Quarter and Year End Results on July 20 2009 49984 2 Allscripts to Announce Fiscal Fourth Quarter and Year End Results on July 20 2009 49984 3 Allscripts to Announce Fiscal Fourth Quarter and Year End Results on July 20 2009 49984 4

[0] MedNet Solutions' ENLIGHTEN Receives CDISC ODM Certification [0] Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration [0] CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures

...ecting Devastating Genetic Diseases -, PHILADELPH...ell connected to other areas, researchers successf...in -- after one injection of,gene therapy. If thes...earchers may have a potential method for gene ther...ital human neurological disorders, such as,Tay-Sac...

...eutics, Inc., a,privately-held biopharmaceutical c...ation of proprietary compounds to treat gastrointe...has completed the patient enrollment,of its Phase ...al,double-blind, placebo controlled study, FHAST1 ...to determine the efficacy and safety of oral,AST-1...

Other Medicine Technology:One Shot of Gene Therapy Spreads Through Brain in Animal Study 2 One Shot of Gene Therapy Spreads Through Brain in Animal Study 3 Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohn's Disease 2 Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohn's Disease 3

One Shot of Gene Therapy Spreads Through Brain in Animal Study Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohn's Disease

...channel within a 12.1mm insertion tube. It featur...d image for improved reliability, an electronic be...5 and 5.0mhz transducer for deeper ultrasound imag...ical orientation and vascular evaluation during re...

...of diagnosis by using the Convex Scanning method. ...od flow by using the Color Flow Mapping and Color ...rated and the balloon fixation has improved. Those...curate techniques. The FG-36UX expands the possibi...

ACL 1000 Coagulation Analyzer

SYNCHRON CX®5 Delta

Medicine Products:

Linear Endoscope Ultrasound (EG-3630U)Linear Endoscope Ultrasound (FG-36Ux)ACL 1000 Coagulation Analyzer SYNCHRON CX®5 Delta

Cyberonics Corporate Headquarters Fully Operational Following Hur...( HOUSTON Sept. 22 /- Cyberonics In...),Health